Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)
Phase: PHASE2 | Sponsor: University Health Network, Toronto | Compound: Psilocybin
- Status
- recruiting
- Institution
- University Health Network, Toronto
- Start date
- 2024-02-05
- End date
- 2028-08-01
- Registry ID
- NCT06341426
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.